AKA: aIP-f (Cachero 2010) , pMP7 (Yu 2010) , MeMe_e10 (Flywire, CTE-FAFB)
| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 14 | 150 | 1,199 | 358.5 | - | - | - | 1,721.5 |
| - | - | - | - | - | 1 | 0.5 | - | - | - | 1.5 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| 2.5 |
| 4.5 |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 3,429 | 95.6% | -10.16 | 3 | 0.2% |
| ME(R) | 119 | 3.3% | 3.46 | 1,307 | 99.1% |
| Optic-unspecified(L) | 30 | 0.8% | -inf | 0 | 0.0% |
| CentralBrain-unspecified | 5 | 0.1% | 0.49 | 7 | 0.5% |
| Optic-unspecified(R) | 4 | 0.1% | -inf | 0 | 0.0% |
| PLP(R) | 0 | 0.0% | inf | 2 | 0.2% |
| upstream partner | # | NT | conns MeVPMe10 | % In | CV |
|---|---|---|---|---|---|
| MeTu3b (L) | 41 | ACh | 353.5 | 20.8% | 0.4 |
| Cm14 (L) | 25 | GABA | 349.5 | 20.6% | 0.7 |
| Dm-DRA1 (L) | 24 | Glu | 313 | 18.4% | 0.3 |
| MeTu2a (L) | 34 | ACh | 162 | 9.5% | 0.4 |
| R7d | 29 | HA | 97.5 | 5.7% | 1.0 |
| Mi15 (L) | 78 | ACh | 74.5 | 4.4% | 0.7 |
| MeTu3a (L) | 20 | ACh | 56.5 | 3.3% | 0.5 |
| Cm4 (L) | 39 | Glu | 55.5 | 3.3% | 0.8 |
| MeTu3c (L) | 43 | ACh | 51 | 3.0% | 0.9 |
| Cm21 (L) | 12 | GABA | 44.5 | 2.6% | 0.8 |
| MeTu2a (R) | 15 | ACh | 17.5 | 1.0% | 0.6 |
| MeTu3b (R) | 16 | ACh | 13.5 | 0.8% | 0.5 |
| Cm31b (L) | 1 | GABA | 12.5 | 0.7% | 0.0 |
| MeVP15 (L) | 7 | ACh | 5.5 | 0.3% | 0.5 |
| MeTu2b (R) | 9 | ACh | 5 | 0.3% | 0.3 |
| Dm2 (L) | 10 | ACh | 5 | 0.3% | 0.0 |
| MeVP6 (L) | 5 | Glu | 4.5 | 0.3% | 0.9 |
| Cm22 (L) | 4 | GABA | 4.5 | 0.3% | 0.5 |
| MeVP14 (L) | 6 | ACh | 4.5 | 0.3% | 0.5 |
| MeTu1 (L) | 8 | ACh | 4.5 | 0.3% | 0.3 |
| Cm20 (L) | 6 | GABA | 3.5 | 0.2% | 0.3 |
| MeVP21 (L) | 2 | ACh | 3 | 0.2% | 0.3 |
| MeTu4d (L) | 3 | ACh | 3 | 0.2% | 0.7 |
| Mi2 (L) | 6 | Glu | 3 | 0.2% | 0.0 |
| Cm14 (R) | 3 | GABA | 2.5 | 0.1% | 0.6 |
| MeTu3a (R) | 4 | ACh | 2.5 | 0.1% | 0.3 |
| Dm-DRA1 (R) | 5 | Glu | 2.5 | 0.1% | 0.0 |
| Tm20 (L) | 2 | ACh | 2 | 0.1% | 0.5 |
| Cm33 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| Cm35 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| Cm9 (L) | 3 | Glu | 2 | 0.1% | 0.4 |
| Cm18 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Cm22 (R) | 4 | GABA | 2 | 0.1% | 0.0 |
| Dm8b (L) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| MeVPMe10 (R) | 2 | Glu | 1.5 | 0.1% | 0.3 |
| Cm8 (L) | 3 | GABA | 1.5 | 0.1% | 0.0 |
| Cm28 (R) | 3 | Glu | 1.5 | 0.1% | 0.0 |
| Mi17 (L) | 1 | GABA | 1 | 0.1% | 0.0 |
| Cm33 (R) | 1 | GABA | 1 | 0.1% | 0.0 |
| MeVC5 (R) | 1 | ACh | 1 | 0.1% | 0.0 |
| Cm16 (L) | 2 | Glu | 1 | 0.1% | 0.0 |
| MeLo5 (L) | 2 | ACh | 1 | 0.1% | 0.0 |
| MeTu2b (L) | 2 | ACh | 1 | 0.1% | 0.0 |
| OA-AL2i4 (L) | 1 | OA | 1 | 0.1% | 0.0 |
| Lat3 (L) | 2 | unc | 1 | 0.1% | 0.0 |
| Mi10 (L) | 2 | ACh | 1 | 0.1% | 0.0 |
| Cm-DRA (L) | 2 | ACh | 1 | 0.1% | 0.0 |
| Mi1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Mi15 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm20 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVP6 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm23 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeTu4a (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm-DRA (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TmY17 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPMe10 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP61 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe25 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC21 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC3 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVC27 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| Cm28 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm4 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| TmY10 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm6 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| ME_LO_unclear (L) | 1 | unc | 0.5 | 0.0% | 0.0 |
| Cm10 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVP12 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm24 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe5 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe9 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe8 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVP45 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm34 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC22 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC20 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPLp2 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe11 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe11 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| downstream partner | # | NT | conns MeVPMe10 | % Out | CV |
|---|---|---|---|---|---|
| MeTu3b (R) | 35 | ACh | 845 | 30.4% | 0.6 |
| MeTu3a (R) | 18 | ACh | 557 | 20.1% | 0.2 |
| Cm22 (R) | 10 | GABA | 361 | 13.0% | 0.3 |
| Cm20 (R) | 13 | GABA | 316.5 | 11.4% | 0.4 |
| MeTu2b (R) | 16 | ACh | 200 | 7.2% | 0.4 |
| Cm14 (R) | 23 | GABA | 134.5 | 4.8% | 1.2 |
| Cm21 (R) | 11 | GABA | 88 | 3.2% | 0.7 |
| Cm10 (R) | 22 | GABA | 43 | 1.5% | 1.1 |
| MeVP39 (R) | 1 | GABA | 42 | 1.5% | 0.0 |
| Pm13 (R) | 1 | Glu | 28.5 | 1.0% | 0.0 |
| Mi14 (R) | 15 | Glu | 24.5 | 0.9% | 0.6 |
| MeLo5 (R) | 9 | ACh | 13.5 | 0.5% | 0.6 |
| MeTu3c (R) | 10 | ACh | 13.5 | 0.5% | 0.7 |
| MeVP31 (R) | 1 | ACh | 9.5 | 0.3% | 0.0 |
| Cm25 (R) | 3 | Glu | 9 | 0.3% | 1.1 |
| Cm28 (R) | 4 | Glu | 8.5 | 0.3% | 0.7 |
| MeVP29 (R) | 1 | ACh | 6 | 0.2% | 0.0 |
| aMe5 (R) | 4 | ACh | 6 | 0.2% | 0.7 |
| MeTu2a (R) | 7 | ACh | 6 | 0.2% | 0.5 |
| Cm16 (R) | 7 | Glu | 5.5 | 0.2% | 0.3 |
| Pm4 (R) | 1 | GABA | 5 | 0.2% | 0.0 |
| Cm3 (R) | 5 | GABA | 4.5 | 0.2% | 0.4 |
| Cm8 (R) | 4 | GABA | 4 | 0.1% | 0.4 |
| TmY10 (R) | 6 | ACh | 3.5 | 0.1% | 0.3 |
| Dm-DRA1 (R) | 2 | Glu | 3 | 0.1% | 0.7 |
| Dm20 (R) | 3 | Glu | 2.5 | 0.1% | 0.6 |
| Tm_unclear (R) | 1 | ACh | 2 | 0.1% | 0.0 |
| aMe17a (R) | 1 | unc | 2 | 0.1% | 0.0 |
| MeVP15 (R) | 3 | ACh | 2 | 0.1% | 0.4 |
| Lawf2 (R) | 2 | ACh | 2 | 0.1% | 0.0 |
| Dm8b (R) | 1 | Glu | 1.5 | 0.1% | 0.0 |
| Cm18 (R) | 2 | Glu | 1.5 | 0.1% | 0.3 |
| Mi15 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm7 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe9 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| OA-AL2i2 (R) | 1 | OA | 1 | 0.0% | 0.0 |
| T2 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm35 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| aMe4 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm-DRA (R) | 2 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe10 (R) | 2 | Glu | 1 | 0.0% | 0.0 |
| MeVC27 (L) | 2 | unc | 1 | 0.0% | 0.0 |
| MeVPMe8 (L) | 2 | Glu | 1 | 0.0% | 0.0 |
| Cm14 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Cm10 (L) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Dm2 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| TmY18 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Tm5c (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm6 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Cm5 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeLo2 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| Tm2 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeTu3a (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPMe8 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| aMe3 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Mi19 (R) | 1 | unc | 0.5 | 0.0% | 0.0 |
| MeVPaMe1 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPMe7 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| Cm35 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| Cm12 (R) | 1 | GABA | 0.5 | 0.0% | 0.0 |
| MeLo6 (R) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| MeVPMe10 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPaMe2 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC20 (R) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPMe7 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC20 (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVC26 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |
| aMe17e (L) | 1 | Glu | 0.5 | 0.0% | 0.0 |
| MeVPLp1 (L) | 1 | ACh | 0.5 | 0.0% | 0.0 |